Company Profile
Evox Therapeutics Limited
10076821•Private Limited With Share Capital
Get Full Access
22/03/2016
10 years
9
40
72110
moderate risk
Company Overview
Registration, classification & business activity
Evox Therapeutics Limited (10076821) is a private limited with share capital incorporated on 22/03/2016 (10 years old) and registered in oxford, OX44HG. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Evox therapeutics is harnessing and engineering the natural trafficking capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics.by combining groundbreaking exosome technology from well-renowned oxford university and the karolinska institutet – the home of the nob...
Financial Overview
£17.65M
£2.82M
£14.83M
£4.49M
£13.84M
Key Metrics
40
Employees
9
Directors
47
Shareholders
28
Patents
Board of Directors
Innovate Grants
This company received a grant of £827243.9 for Exosome Therapy For Rare Paediatric Disorder Argininosuccinic Aciduria. The project started on 01/02/2019 and ended on 31/03/2021.
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
excellent
Performance Rating